Stock A179530 ADBIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company ADBiotech Co., Ltd.

Equities

A179530

KR7179530001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-18 pm EDT 		5-day change 1st Jan Change
3,075 KRW -3.30% Intraday chart for ADBiotech Co., Ltd. +3.54% -6.11%
Apr. 26 ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd CI
Apr. 25 ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd CI

Business Summary

ADBiotech Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of veterinary drugs. The Company operates its business through two segments. Veterinary Medicine segment is engaged in the manufacture and sale of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, synthetic antibacterial agents and others. The Supplementary Feed segment is engaged in the manufacture and sale of functional supplementary feeds and other products.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Biotechnology
82.1 %
- - 8,599 82.1 % -
Online Platforms
17.9 %
- - 1,875 17.9 % -
Consolidation Adjustment
0.0 %
- - -2 0.0 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
77.1 %
8,277 77.9 % 8,074 77.1 % -2.45%
Asia
22.9 %
2,355 22.1 % 2,398 22.9 % +1.84%

Managers

Managers TitleAgeSince
Hong-Geol Jeong CEO
 Chief Executive Officer 62 -
Nam-Hyeong Lee CTO
 Chief Tech/Sci/R&D Officer 78 -
Woo-Bok Kim AUD
 Comptroller/Controller/Auditor 42 -

Members of the board

Members of the board TitleAgeSince
Yang-Woo Jeon BRD
 Director/Board Member 64 -
Hong-Geol Jeong CEO
 Chief Executive Officer 62 -
Nam-Hyeong Lee CTO
 Chief Tech/Sci/R&D Officer 78 -
Soo-Hyeon Kim BRD
 Director/Board Member 66 -
Ju-Young Kim BRD
 Director/Board Member 45 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,140,444 5,437,018 ( 59.48 %) 0 59.48 %

Company contact information

ADbiotech Co., Ltd.

39, Geodudanji 1-gil Dongnae-myeon

24398, Chuncheon-si

+

http://www.adbiotech.com
address ADBiotech Co., Ltd.(A179530)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Veterinary Drugs

Sales per Business

Sales per region

Sector Veterinary Drugs

1st Jan change Capi.
ADBIOTECH CO., LTD. Stock ADBiotech Co., Ltd.
-6.11% 21.05M
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
+21.88% 8.97B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+22.25% 3.66B
VIRBAC Stock Virbac
-4.59% 3.13B
VIMIAN GROUP AB Stock Vimian Group AB
+12.16% 1.67B
VETOQUINOL SA Stock Vetoquinol SA
-5.18% 1.25B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-30.83% 1.17B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-31.96% 1.16B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-24.53% 1.01B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. Stock Tianjin Ringpu Bio-Technology Co.,Ltd.
-13.36% 931M
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. A179530 Stock
  4. Company ADBiotech Co., Ltd.